Heritability of Biomarkers of Oxidized Lipoproteins Twin Pair Study

被引:41
作者
Rao, Fangwen [1 ]
Schork, Andrew J. [1 ]
Maihofer, Adam X. [2 ]
Nievergelt, Caroline M. [2 ]
Marcovina, Santica M. [3 ]
Miller, Elizabeth R. [1 ]
Witztum, Joseph L. [1 ]
O'Connor, Daniel T. [1 ]
Tsimikas, Sotirios [1 ]
机构
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92993 USA
[2] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92993 USA
[3] Univ Washington, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
atherosclerosis; genetics; lipoprotein(a); lipoproteins; oxidation; thrombosis; twins; LOW-DENSITY-LIPOPROTEIN; OXIDATION-SPECIFIC EPITOPES; APOLIPOPROTEIN B-100 PARTICLES; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR EVENTS; RISK-FACTOR; ATHEROSCLEROTIC LESIONS; MYOCARDIAL-INFARCTION; NET RECLASSIFICATION; LP(A) LIPOPROTEIN;
D O I
10.1161/ATVBAHA.115.305306
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine whether biomarkers of oxidized lipoproteins are genetically determined. Lipoprotein(a) (Lp[a]) is a heritable risk factor and carrier of oxidized phospholipids (OxPL). Approach and Results We measured oxidized phospholipids on apolipoprotein B-containing lipoproteins (OxPL-apoB), Lp(a), IgG, and IgM autoantibodies to malondialdehyde-modified low-density lipoprotein, copper oxidized low-density lipoprotein, and apoB-immune complexes in 386 monozygotic and dizygotic twins to estimate trait heritability (h(2)) and determine specific genetic effects among traits. A genome-wide linkage study followed by genetic association was performed. The h(2) (scale: 0-1) for Lp(a) was 0.910.01 and for OxPL-apoB 0.87 +/- 0.02, which were higher than physiological, inflammatory, or lipid traits. h(2) of IgM malondialdehyde-modified low-density lipoprotein, copper oxidized low-density lipoprotein, and apoB-immune complexes were 0.69 +/- 0.04, 0.67 +/- 0.05, and 0.80 +/- 0.03, respectively, and for IgG malondialdehyde-modified low-density lipoprotein, copper oxidized low-density lipoprotein, and apoB-immune complexes 0.62 +/- 0.05, 0.52 +/- 0.06, and 0.53 +/- 0.06, respectively. There was an inverse correlation between the major apo(a) isoform and OxPL-apoB (R=-0.49; P<0.001) and Lp(a) (R=-0.48; P<0.001) and OxPL-apoB was modestly correlated with Lp(a) (=0.57; P<0.0001). The correlation in major apo(a) isoform size was concordant (R=1.0; P<0.001) among monozygotic twins but not dizygotic twins (R=0.40; P=0.055). Lp(a) and OxPL-apoB shared genetic codetermination (genetic covariance, G=0.774 +/- 0.032; P=1.09x10(-38)), although not environmental determination (environmental covariance, E=0.081 +/- 0.15; P=0.15). In contrast, Lp(a) shared environmental but not genetic codetermination with autoantibodies to malondialdehyde-modified low-density lipoprotein and copper oxidized low-density lipoprotein, and apoB-immune complexes. Sib-pair genetic linkage of the Lp(a) trait revealed that single nucleotide polymorphism rs10455872 was significantly associated with OxPL-apoB after adjusting for Lp(a). Conclusions OxPL-apoB and other biomarkers of oxidized lipoproteins are highly heritable cardiovascular risk factors that suggest novel genetic origins of atherothrombosis.
引用
收藏
页码:1704 / 1711
页数:8
相关论文
共 41 条
[1]   Evidence mounts for a role of the kidney in lipoprotein(a) catabolism [J].
Albers, J. J. ;
Koschinsky, M. L. ;
Marcovina, S. M. .
KIDNEY INTERNATIONAL, 2007, 71 (10) :961-962
[2]   The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles [J].
Arai, Kiyohito ;
Luke, May M. ;
Koschinsky, Marlys L. ;
Miller, Elizabeth R. ;
Pullinger, Clive R. ;
Witztum, Joseph L. ;
Kane, John P. ;
Tsimikas, Sotirios .
ATHEROSCLEROSIS, 2010, 209 (02) :498-503
[3]  
AUSTIN MA, 1992, AM J HUM GENET, V51, P829
[4]   A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma [J].
Bergmark, Claes ;
Dewan, Asheesh ;
Orsoni, Alexina ;
Merki, Esther ;
Miller, Elizabeth R. ;
Shin, Min-Jeong ;
Binder, Christoph J. ;
Horkko, Sohvi ;
Krauss, Ronald M. ;
Chapman, M. John ;
Witztum, Joseph L. ;
Tsimikas, Sotirios .
JOURNAL OF LIPID RESEARCH, 2008, 49 (10) :2230-2239
[5]   Oxidation-Specific Biomarkers and Risk of Peripheral Artery Disease [J].
Bertoia, Monica L. ;
Pai, Jennifer K. ;
Lee, Jun-Hee ;
Taleb, Adam ;
Joosten, Michel M. ;
Mittleman, Murray A. ;
Yang, Xiaohong ;
Witztum, Joseph L. ;
Rimm, Eric B. ;
Tsimikas, Sotirios ;
Mukamal, Kenneth J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (21) :2169-2179
[6]   Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans [J].
Chou, Meng-Yun ;
Fogelstrand, Linda ;
Hartvigsen, Karsten ;
Hansen, Lotte F. ;
Woelkers, Douglas ;
Shaw, Peter X. ;
Choi, Jeomil ;
Perkmann, Thomas ;
Backhed, Fredrik ;
Miller, Yury I. ;
Hoerkkoe, Sohvi ;
Corr, Maripat ;
Witztum, Joseph L. ;
Binder, Christoph J. .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (05) :1335-1349
[7]   Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease [J].
Clarke, Robert ;
Peden, John F. ;
Hopewell, Jemma C. ;
Kyriakou, Theodosios ;
Goel, Anuj ;
Heath, Simon C. ;
Parish, Sarah ;
Barlera, Simona ;
Franzosi, Maria Grazia ;
Rust, Stephan ;
Bennett, Derrick ;
Silveira, Angela ;
Malarstig, Anders ;
Green, Fiona R. ;
Lathrop, Mark ;
Gigante, Bruna ;
Leander, Karin ;
de Faire, Ulf ;
Seedorf, Udo ;
Hamsten, Anders ;
Collins, Rory ;
Watkins, Hugh ;
Farrall, Martin .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (26) :2518-2528
[8]  
Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063
[9]  
Gounopoulos P, 2007, Minerva Cardioangiol, V55, P821
[10]   Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome [J].
Holvoet, Paul ;
Lee, Duk-Hee ;
Steffes, Michael ;
Gross, Myron ;
Jacobs, David R., Jr. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (19) :2287-2293